Moreover, patients with severe AT III deficiency had higher in-hospital mortality, and AT III plasma levels demonstrated good predictive performance for overt DIC in ECMO patients. This evidence concerns the gene SERPINC1 and hyperinsulinemic hypoglycemia, familial, 4.